カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の肺サーファクタント市場2022年：気管内、注射可能

◆英語タイトル：Global Lung Surfactants Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8883 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：90 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

肺サーファクタント市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の肺サーファクタントの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

肺サーファクタント市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・気管内、注射可能

用途別セグメントは次のように区分されます。
・病院、特別クリニック、回復センター

世界の肺サーファクタント市場の主要な市場プレーヤーは以下のとおりです。
・Chiesi Farmaceutici、AbbVie、ONY Biotech、Lyomark Pharma、Windtree Therapeutics、Aviva Systems Biology Corporation

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、肺サーファクタント製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な肺サーファクタントメーカーの企業概要、2019年～2022年までの肺サーファクタントの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な肺サーファクタントメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別肺サーファクタントの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの肺サーファクタントの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での肺サーファクタント市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および肺サーファクタントの産業チェーンを掲載しています。
・第13、14、15章では、肺サーファクタントの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Chiesi Farmaceutici、AbbVie、ONY Biotech、Lyomark Pharma、Windtree Therapeutics、Aviva Systems Biology Corporation
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：気管内、注射可能
・用途別分析2017年-2028年：病院、特別クリニック、回復センター
・肺サーファクタントの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・肺サーファクタントのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・肺サーファクタントのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・肺サーファクタントの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・肺サーファクタントの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Lung Surfactants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Lung Surfactants market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Lung Surfactants global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intratracheal segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Lung Surfactants include Chiesi Farmaceutici, AbbVie, ONY Biotech, Lyomark Pharma, and Windtree Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Lung Surfactants market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intratracheal
Injectable
Market segment by Application can be divided into
Hospital
Special Clinic
Recovery Center
The key market players for global Lung Surfactants market are listed below:
Chiesi Farmaceutici
AbbVie
ONY Biotech
Lyomark Pharma
Windtree Therapeutics
Aviva Systems Biology Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lung Surfactants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lung Surfactants, with price, sales, revenue and global market share of Lung Surfactants from 2019 to 2022.
Chapter 3, the Lung Surfactants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lung Surfactants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Lung Surfactants market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Surfactants.
Chapter 13, 14, and 15, to describe Lung Surfactants sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Lung Surfactants Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lung Surfactants Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intratracheal
1.2.3 Injectable
1.3 Market Analysis by Application
1.3.1 Overview: Global Lung Surfactants Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Special Clinic
1.3.4 Recovery Center
1.4 Global Lung Surfactants Market Size & Forecast
1.4.1 Global Lung Surfactants Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Lung Surfactants Sales in Volume (2017-2028)
1.4.3 Global Lung Surfactants Price (2017-2028)
1.5 Global Lung Surfactants Production Capacity Analysis
1.5.1 Global Lung Surfactants Total Production Capacity (2017-2028)
1.5.2 Global Lung Surfactants Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Lung Surfactants Market Drivers
1.6.2 Lung Surfactants Market Restraints
1.6.3 Lung Surfactants Trends Analysis
2 Manufacturers Profiles
2.1 Chiesi Farmaceutici
2.1.1 Chiesi Farmaceutici Details
2.1.2 Chiesi Farmaceutici Major Business
2.1.3 Chiesi Farmaceutici Lung Surfactants Product and Services
2.1.4 Chiesi Farmaceutici Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Lung Surfactants Product and Services
2.2.4 AbbVie Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 ONY Biotech
2.3.1 ONY Biotech Details
2.3.2 ONY Biotech Major Business
2.3.3 ONY Biotech Lung Surfactants Product and Services
2.3.4 ONY Biotech Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lyomark Pharma
2.4.1 Lyomark Pharma Details
2.4.2 Lyomark Pharma Major Business
2.4.3 Lyomark Pharma Lung Surfactants Product and Services
2.4.4 Lyomark Pharma Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Windtree Therapeutics
2.5.1 Windtree Therapeutics Details
2.5.2 Windtree Therapeutics Major Business
2.5.3 Windtree Therapeutics Lung Surfactants Product and Services
2.5.4 Windtree Therapeutics Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Aviva Systems Biology Corporation
2.6.1 Aviva Systems Biology Corporation Details
2.6.2 Aviva Systems Biology Corporation Major Business
2.6.3 Aviva Systems Biology Corporation Lung Surfactants Product and Services
2.6.4 Aviva Systems Biology Corporation Lung Surfactants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Lung Surfactants Breakdown Data by Manufacturer
3.1 Global Lung Surfactants Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Lung Surfactants Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Lung Surfactants
3.4 Market Concentration Rate
3.4.1 Top 3 Lung Surfactants Manufacturer Market Share in 2021
3.4.2 Top 6 Lung Surfactants Manufacturer Market Share in 2021
3.5 Global Lung Surfactants Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Lung Surfactants Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Lung Surfactants Market Size by Region
4.1.1 Global Lung Surfactants Sales in Volume by Region (2017-2028)
4.1.2 Global Lung Surfactants Revenue by Region (2017-2028)
4.2 North America Lung Surfactants Revenue (2017-2028)
4.3 Europe Lung Surfactants Revenue (2017-2028)
4.4 Asia-Pacific Lung Surfactants Revenue (2017-2028)
4.5 South America Lung Surfactants Revenue (2017-2028)
4.6 Middle East and Africa Lung Surfactants Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Lung Surfactants Sales in Volume by Type (2017-2028)
5.2 Global Lung Surfactants Revenue by Type (2017-2028)
5.3 Global Lung Surfactants Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Lung Surfactants Sales in Volume by Application (2017-2028)
6.2 Global Lung Surfactants Revenue by Application (2017-2028)
6.3 Global Lung Surfactants Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Lung Surfactants Sales by Type (2017-2028)
7.2 North America Lung Surfactants Sales by Application (2017-2028)
7.3 North America Lung Surfactants Market Size by Country
7.3.1 North America Lung Surfactants Sales in Volume by Country (2017-2028)
7.3.2 North America Lung Surfactants Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Lung Surfactants Sales by Type (2017-2028)
8.2 Europe Lung Surfactants Sales by Application (2017-2028)
8.3 Europe Lung Surfactants Market Size by Country
8.3.1 Europe Lung Surfactants Sales in Volume by Country (2017-2028)
8.3.2 Europe Lung Surfactants Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Lung Surfactants Sales by Type (2017-2028)
9.2 Asia-Pacific Lung Surfactants Sales by Application (2017-2028)
9.3 Asia-Pacific Lung Surfactants Market Size by Region
9.3.1 Asia-Pacific Lung Surfactants Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Lung Surfactants Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Lung Surfactants Sales by Type (2017-2028)
10.2 South America Lung Surfactants Sales by Application (2017-2028)
10.3 South America Lung Surfactants Market Size by Country
10.3.1 South America Lung Surfactants Sales in Volume by Country (2017-2028)
10.3.2 South America Lung Surfactants Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Lung Surfactants Sales by Type (2017-2028)
11.2 Middle East & Africa Lung Surfactants Sales by Application (2017-2028)
11.3 Middle East & Africa Lung Surfactants Market Size by Country
11.3.1 Middle East & Africa Lung Surfactants Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Lung Surfactants Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Lung Surfactants and Key Manufacturers
12.2 Manufacturing Costs Percentage of Lung Surfactants
12.3 Lung Surfactants Production Process
12.4 Lung Surfactants Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Lung Surfactants Typical Distributors
13.3 Lung Surfactants Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Lung Surfactants Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Lung Surfactants Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 4. Chiesi Farmaceutici Major Business
Table 5. Chiesi Farmaceutici Lung Surfactants Product and Services
Table 6. Chiesi Farmaceutici Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Major Business
Table 9. AbbVie Lung Surfactants Product and Services
Table 10. AbbVie Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. ONY Biotech Basic Information, Manufacturing Base and Competitors
Table 12. ONY Biotech Major Business
Table 13. ONY Biotech Lung Surfactants Product and Services
Table 14. ONY Biotech Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Lyomark Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Lyomark Pharma Major Business
Table 17. Lyomark Pharma Lung Surfactants Product and Services
Table 18. Lyomark Pharma Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Windtree Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Windtree Therapeutics Major Business
Table 21. Windtree Therapeutics Lung Surfactants Product and Services
Table 22. Windtree Therapeutics Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Aviva Systems Biology Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Aviva Systems Biology Corporation Major Business
Table 25. Aviva Systems Biology Corporation Lung Surfactants Product and Services
Table 26. Aviva Systems Biology Corporation Lung Surfactants Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Lung Surfactants Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Lung Surfactants Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Lung Surfactants, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Lung Surfactants Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Lung Surfactants Production Site of Key Manufacturer
Table 32. Lung Surfactants New Entrant and Capacity Expansion Plans
Table 33. Lung Surfactants Mergers & Acquisitions in the Past Five Years
Table 34. Global Lung Surfactants Sales by Region (2017-2022) & (K Units)
Table 35. Global Lung Surfactants Sales by Region (2023-2028) & (K Units)
Table 36. Global Lung Surfactants Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Lung Surfactants Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Lung Surfactants Sales by Type (2017-2022) & (K Units)
Table 39. Global Lung Surfactants Sales by Type (2023-2028) & (K Units)
Table 40. Global Lung Surfactants Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Lung Surfactants Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Lung Surfactants Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Lung Surfactants Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Lung Surfactants Sales by Application (2017-2022) & (K Units)
Table 45. Global Lung Surfactants Sales by Application (2023-2028) & (K Units)
Table 46. Global Lung Surfactants Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Lung Surfactants Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Lung Surfactants Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Lung Surfactants Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Lung Surfactants Sales by Country (2017-2022) & (K Units)
Table 51. North America Lung Surfactants Sales by Country (2023-2028) & (K Units)
Table 52. North America Lung Surfactants Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Lung Surfactants Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Lung Surfactants Sales by Type (2017-2022) & (K Units)
Table 55. North America Lung Surfactants Sales by Type (2023-2028) & (K Units)
Table 56. North America Lung Surfactants Sales by Application (2017-2022) & (K Units)
Table 57. North America Lung Surfactants Sales by Application (2023-2028) & (K Units)
Table 58. Europe Lung Surfactants Sales by Country (2017-2022) & (K Units)
Table 59. Europe Lung Surfactants Sales by Country (2023-2028) & (K Units)
Table 60. Europe Lung Surfactants Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Lung Surfactants Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Lung Surfactants Sales by Type (2017-2022) & (K Units)
Table 63. Europe Lung Surfactants Sales by Type (2023-2028) & (K Units)
Table 64. Europe Lung Surfactants Sales by Application (2017-2022) & (K Units)
Table 65. Europe Lung Surfactants Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Lung Surfactants Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Lung Surfactants Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Lung Surfactants Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Lung Surfactants Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Lung Surfactants Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Lung Surfactants Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Lung Surfactants Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Lung Surfactants Sales by Application (2023-2028) & (K Units)
Table 74. South America Lung Surfactants Sales by Country (2017-2022) & (K Units)
Table 75. South America Lung Surfactants Sales by Country (2023-2028) & (K Units)
Table 76. South America Lung Surfactants Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Lung Surfactants Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Lung Surfactants Sales by Type (2017-2022) & (K Units)
Table 79. South America Lung Surfactants Sales by Type (2023-2028) & (K Units)
Table 80. South America Lung Surfactants Sales by Application (2017-2022) & (K Units)
Table 81. South America Lung Surfactants Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Lung Surfactants Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Lung Surfactants Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Lung Surfactants Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Lung Surfactants Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Lung Surfactants Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Lung Surfactants Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Lung Surfactants Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Lung Surfactants Sales by Application (2023-2028) & (K Units)
Table 90. Lung Surfactants Raw Material
Table 91. Key Manufacturers of Lung Surfactants Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Lung Surfactants Typical Distributors
Table 95. Lung Surfactants Typical Customers
List of Figures
Figure 1. Lung Surfactants Picture
Figure 2. Global Lung Surfactants Revenue Market Share by Type in 2021
Figure 3. Intratracheal
Figure 4. Injectable
Figure 5. Global Lung Surfactants Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Special Clinic
Figure 8. Recovery Center
Figure 9. Global Lung Surfactants Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Lung Surfactants Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Lung Surfactants Sales (2017-2028) & (K Units)
Figure 12. Global Lung Surfactants Price (2017-2028) & (US$/Unit)
Figure 13. Global Lung Surfactants Production Capacity (2017-2028) & (K Units)
Figure 14. Global Lung Surfactants Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Lung Surfactants Market Drivers
Figure 16. Lung Surfactants Market Restraints
Figure 17. Lung Surfactants Market Trends
Figure 18. Global Lung Surfactants Sales Market Share by Manufacturer in 2021
Figure 19. Global Lung Surfactants Revenue Market Share by Manufacturer in 2021
Figure 20. Lung Surfactants Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Lung Surfactants Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Lung Surfactants Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Lung Surfactants Sales Market Share by Region (2017-2028)
Figure 24. Global Lung Surfactants Revenue Market Share by Region (2017-2028)
Figure 25. North America Lung Surfactants Revenue (2017-2028) & (USD Million)
Figure 26. Europe Lung Surfactants Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Lung Surfactants Revenue (2017-2028) & (USD Million)
Figure 28. South America Lung Surfactants Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Lung Surfactants Revenue (2017-2028) & (USD Million)
Figure 30. Global Lung Surfactants Sales Market Share by Type (2017-2028)
Figure 31. Global Lung Surfactants Revenue Market Share by Type (2017-2028)
Figure 32. Global Lung Surfactants Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Lung Surfactants Sales Market Share by Application (2017-2028)
Figure 34. Global Lung Surfactants Revenue Market Share by Application (2017-2028)
Figure 35. Global Lung Surfactants Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Lung Surfactants Sales Market Share by Type (2017-2028)
Figure 37. North America Lung Surfactants Sales Market Share by Application (2017-2028)
Figure 38. North America Lung Surfactants Sales Market Share by Country (2017-2028)
Figure 39. North America Lung Surfactants Revenue Market Share by Country (2017-2028)
Figure 40. United States Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Lung Surfactants Sales Market Share by Type (2017-2028)
Figure 44. Europe Lung Surfactants Sales Market Share by Application (2017-2028)
Figure 45. Europe Lung Surfactants Sales Market Share by Country (2017-2028)
Figure 46. Europe Lung Surfactants Revenue Market Share by Country (2017-2028)
Figure 47. Germany Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Lung Surfactants Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Lung Surfactants Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Lung Surfactants Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Lung Surfactants Revenue Market Share by Region (2017-2028)
Figure 56. China Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Lung Surfactants Sales Market Share by Type (2017-2028)
Figure 63. South America Lung Surfactants Sales Market Share by Application (2017-2028)
Figure 64. South America Lung Surfactants Sales Market Share by Country (2017-2028)
Figure 65. South America Lung Surfactants Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Lung Surfactants Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Lung Surfactants Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Lung Surfactants Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Lung Surfactants Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Lung Surfactants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Lung Surfactants in 2021
Figure 77. Manufacturing Process Analysis of Lung Surfactants
Figure 78. Lung Surfactants Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の肺サーファクタント市場2022年：気管内、注射可能(Global Lung Surfactants Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の肺サーファクタント市場2022年：気管内、注射可能

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp